CULLINAN THERAPEUTICS
16.51
07-11月-24 11:17:30
15 分の遅延
株式
+0.03
+0.18%
本日の幅
16.35 - 17.19
ISIN
N/A
ソース
NASDAQ
-
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
07 11 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
05 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
04 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
17 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
16 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
14 9 2024 04:15:00 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
28 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
08 8 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
01 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
24 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
23 5 2024 17:04:38 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
29 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
16 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
16 4 2024 06:59:00 提供 Nasdaq GlobeNewswire
-
14 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
01 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
27 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >